HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amifostine modulates radio-induced apoptosis of peripheral blood lymphocytes in head and neck cancer patients.

Abstract
Head and neck cancer is treated mainly with surgery and radiotherapy. Xerostomia and mucositis are common adverse effects of radiation therapy. One of the strategies aimed at decreasing radiation toxicity is the use of radioprotective agents, such as amifostine. We previously reported that radio induced apoptosis of peripheral blood lymphocytes was statistically associated with normal tissue toxicity in the form of severe xerostomia. The aim of the present study was to explore the effects of amifostine on the radiation-induced apoptosis of peripheral blood lymphocytes from patients suffering head and neck cancer. Eighteen consecutive patients with squamous cell carcinoma of the head and neck were included in the study. Peripheral blood lymphocytes were isolated before and after the treatment with amifostine. Then, cells were irradiated at 0, 1, 2 and 8 Gy during 24 hours. Apoptosis was measured by flow cytometry using annexin V/propidium iodide. As expected, radio-induced apoptosis values fitted to a semi logarithmic equation as follows: RIA = β ln(Gy) + α. The administration of amifostine prior to radiation therapy modulates radio-induced apoptosis of peripheral blood lymphocytes: 13.68 vs. 13.37 (P = 0.027), 19.11 vs. 17.64 (P = 0.001) and 30.70 vs. 28.84 (P = 0.001), before and after the administration of the drug for 1, 2 and 8 Gy respectively. α and β decreased significantly after the administration of the drug: 13.58 vs. 12.99 (P = 0.009) and 8.21 vs. 7.53 (P = 0.017), respectively. Our results provide new information about the biological actions of amifostine in vivo.
AuthorsMaite M Saavedra, Luis Alberto Henríquez-Hernández, Pedro C Lara, Beatriz Pinar, Carlos Rodríguez-Gallego, Marta Lloret
JournalJournal of radiation research (J Radiat Res) Vol. 51 Issue 5 Pg. 603-7 ( 2010) ISSN: 1349-9157 [Electronic] England
PMID20699603 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Radiation-Protective Agents
  • Amifostine
Topics
  • Adult
  • Aged
  • Amifostine (pharmacology)
  • Apoptosis (drug effects)
  • Carcinoma, Squamous Cell
  • Cells, Cultured
  • Head and Neck Neoplasms (drug therapy, radiotherapy)
  • Humans
  • Lymphocytes (drug effects, radiation effects)
  • Male
  • Middle Aged
  • Radiation Injuries
  • Radiation-Protective Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: